BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22480666)

  • 1. Increases in the availability of prescribed opioids in a Canadian setting.
    Nosyk B; Marshall BD; Fischer B; Montaner JS; Wood E; Kerr T
    Drug Alcohol Depend; 2012 Nov; 126(1-2):7-12. PubMed ID: 22480666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing availability of illicit and prescription opioids among people who inject drugs in a Canadian setting, 2010-2014.
    Ho J; DeBeck K; Milloy MJ; Dong H; Wood E; Kerr T; Hayashi K
    Am J Drug Alcohol Abuse; 2018; 44(3):368-377. PubMed ID: 29048952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How many people in Canada use prescription opioids non-medically in general and street drug using populations?
    Popova S; Patra J; Mohapatra S; Fischer B; Rehm J
    Can J Public Health; 2009; 100(2):104-8. PubMed ID: 19839284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of, and Factors Associated With, Illicit Pharmaceutical Opioid Analgesic Use in a Prospective Cohort of People Who Inject Drugs in Melbourne, Australia.
    Horyniak D; Agius PA; Degenhardt L; Reddel S; Higgs P; Aitken C; Stoové M; Dietze P
    Subst Use Misuse; 2015; 50(13):1650-9. PubMed ID: 26576630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review.
    Fischer B; Argento E
    Pain Physician; 2012 Jul; 15(3 Suppl):ES191-203. PubMed ID: 22786457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seeking prescription opioids from physicians for nonmedical use among people who inject drugs in a Canadian setting.
    Kennedy MC; Kerr T; DeBeck K; Dong H; Milloy MJ; Wood E; Hayashi K
    Am J Addict; 2016 Jun; 25(4):275-82. PubMed ID: 27143485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.
    Puzhko S; Roy É; Jutras-Aswad D; Artenie AA; Fortier E; Zang G; Bruneau J
    Int J Drug Policy; 2017 Sep; 47():61-68. PubMed ID: 28666636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs.
    Lake S; Hayashi K; Buxton J; Milloy MJ; Dong H; Wood E; Montaner J; Kerr T
    Drug Alcohol Depend; 2015 Nov; 156():297-303. PubMed ID: 26454837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
    Atluri S; Sudarshan G; Manchikanti L
    Pain Physician; 2014; 17(2):E119-28. PubMed ID: 24658483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States city.
    Setnik B; Roland CL; Goli V; Pixton GC; Levy-Cooperman N; Smith I; Webster L
    J Opioid Manag; 2015; 11(6):463-73. PubMed ID: 26728643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.
    Dong H; Hayashi K; Milloy MJ; DeBeck K; Singer J; Wong H; Wood E; Kerr T
    Drug Alcohol Depend; 2020 Jul; 212():108005. PubMed ID: 32370932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users.
    Fischer B; Patra J; Cruz MF; Gittins J; Rehm J
    Drug Alcohol Rev; 2008 Nov; 27(6):625-32. PubMed ID: 19378446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cohort profile: development and characteristics of a retrospective cohort of individuals dispensed prescription opioids for non-cancer pain in British Columbia, Canada.
    Wilton J; Chong M; Abdia Y; Purssell R; MacInnes A; Gomes T; Dart RC; Balshaw RF; Otterstatter M; Wong S; Yu A; Alvarez M; Janjua NZ; Buxton JA
    BMJ Open; 2021 Apr; 11(4):e043586. PubMed ID: 33849849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdose Risk and Acquiring Opioids for Nonmedical Use Exclusively from Physicians in Vancouver, Canada.
    Cheng T; Small W; Nosova E; Hogg R; Hayashi K; Kerr T; DeBeck K
    Subst Use Misuse; 2020; 55(12):1912-1918. PubMed ID: 32589497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription Opioid Injection Among HIV-Positive People Who Inject Drugs in a Canadian Setting.
    Lake S; Kerr T; Buxton J; Guillemi S; Parashar S; Montaner J; Wood E; Milloy MJ
    AIDS Behav; 2016 Dec; 20(12):2941-2949. PubMed ID: 27146887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription opioid use, misuse, and diversion among street drug users in New York City.
    Davis WR; Johnson BD
    Drug Alcohol Depend; 2008 Jan; 92(1-3):267-76. PubMed ID: 17913395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?
    Fischer B; Keates A; Bühringer G; Reimer J; Rehm J
    Addiction; 2014 Feb; 109(2):177-81. PubMed ID: 23692335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription opioid use and non-fatal overdose in a cohort of injection drug users.
    Lake S; Wood E; Buxton J; Dong H; Montaner J; Kerr T
    Am J Drug Alcohol Abuse; 2015 May; 41(3):257-63. PubMed ID: 25699628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription opioid misuse: characteristics of earliest and most recent memory of hydromorphone use.
    Fulton HG; Barrett SP; Stewart SH; Macisaac C
    J Addict Med; 2012 Jun; 6(2):137-44. PubMed ID: 22105062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.